# Beam Therapeutics (BEAM): value investors who own it

1 value investor held Beam Therapeutics in their Q3 2026 13F, led by Horizon Kinetics. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Horizon Kinetics | 0.0% | $288k | Trimmed -4.6% | 4 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-16 | Evans John M. | CEO | Sold | 25000 | $600k |
| 2026-10-15 | Evans John M. | CEO | Sold | 25000 | $589k |
| 2026-10-01 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sold | 187 | $5k |
| 2026-07-27 | Simon Amy | Chief Medical Officer | Sold | 16667 | $429k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/beam). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.